MAML1 regulates cell viability via the NF-κB pathway in cervical cancer cell lines

Experimental Cell Research

Volumn 317, Issue 13, 2011, Pages 1830-1840

  Kuncharin, Yanin ^a   Sangphech, Naunpun ^a   Kueanjinda, Patipark ^a   Bhattarakosol, Parvapan ^a   Palaga, Tanapat ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Cervical cancer; Dominant negative; MAML; NF B; Notch signaling

Indexed keywords

GAMMA SECRETASE INHIBITOR; I KAPPA B; I KAPPA B ALPHA; MESSENGER RNA; NOTCH RECEPTOR; NOTCH1 RECEPTOR; PROTEIN MASTERMIND LIKE 1; PROTEIN P53; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HES 1; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL VIABILITY; CLONOGENESIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; UTERINE CERVIX CANCER; VECTOR CONTROL; WART VIRUS;

HUMAN PAPILLOMAVIRUS;

EID: 79959339086     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2011.05.005     Document Type: Article

References (26)

1. Artavanis-Tsakonas S., Rand M.D., Lake R.J. Notch signaling: cell fate control and signal integration in development. Science 1999, 284:770-776.
2. Radtke F., Raj K. The role of Notch in tumorigenesis: oncogene or tumour suppressor?. Nat. Rev. Cancer 2003, 3:756-767.
3. Radtke F., Fasnacht N., Macdonald H.R. Notch signaling in the immune system. Immunity 2010, 32:14-27.
4. Zagouras P., Stifani S., Blaumueller C.M., Carcangiu M.L., Artavanis-Tsakonas S. Alterations in Notch signaling in neoplastic lesions of the human cervix. Proc. Natl Acad. Sci. U. S. A. 1995, 92:6414-6418.
5. Talora C., Sgroi D.C., Crum C.P., Dotto G.P. Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation. Genes Dev. 2002, 16:2252-2263.
6. Rangarajan A., Syal R., Selvarajah S., Chakrabarti O., Sarin A., Krishna S. Activated Notch1 signaling cooperates with papillomavirus oncogenes in transformation and generates resistance to apoptosis on matrix withdrawal through PKB/Akt. Virology 2001, 286:23-30.
7. Weijzen S., Zlobin A., Braid M., Miele L., Kast W.M. HPV16 E6 and E7 oncoproteins regulate Notch-1 expression and cooperate to induce transformation. J. Cell. Physiol. 2003, 194:356-362.
8. Yao J., Duan L., Fan M., Yuan J., Wu X. Notch1 induces cell cycle arrest and apoptosis in human cervical cancer cells: involvement of nuclear factor kappa B inhibition. Int. J. Gynecol. Cancer 2007, 17:502-510.
9. Ramdass B., Maliekal T.T., Lakshmi S., Rehman M., Rema P., Nair P., Mukherjee G., Reddy B.K., Krishna S., Radhakrishna Pillai M. Coexpression of Notch1 and NF-kappaB signaling pathway components in human cervical cancer progression. Gynecol. Oncol. 2007, 104:352-361.
10. Song L.L., Peng Y., Yun J., Rizzo P., Chaturvedi V., Weijzen S., Kast W.M., Stone P.J., Santos L., Loredo A., Lendahl U., Sonenshein G., Osborne B., Qin J.Z., Pannuti A., Nickoloff B.J., Miele L. Notch-1 associates with IKKalpha and regulates IKK activity in cervical cancer cells. Oncogene 2008, 27:5833-5844.
11. Talora C., Cialfi S., Segatto O., Morrone S., Kim Choi J., Frati L., Paolo Dotto G., Gulino A., Screpanti I. Constitutively active Notch1 induces growth arrest of HPV-positive cervical cancer cells via separate signaling pathways. Exp. Cell Res. 2005, 305:343-354.
12. Wang L., Qin H., Chen B., Xin X., Li J., Han H. Overexpressed active Notch1 induces cell growth arrest of HeLa cervical carcinoma cells. Int. J. Gynecol. Cancer 2007, 17:1283-1292.
13. Maliekal T.T., Bajaj J., Giri V., Subramanyam D., Krishna S. The role of Notch signaling in human cervical cancer: implications for solid tumors. Oncogene 2008, 27:5110-5114.
14. Wu L., Sun T., Kobayashi K., Gao P., Griffin J.D. Identification of a family of mastermind-like transcriptional coactivators for mammalian notch receptors. Mol. Cell. Biol. 2002, 22:7688-7700.
15. Wu L., Griffin J.D. Modulation of Notch signaling by mastermind-like (MAML) transcriptional co-activators and their involvement in tumorigenesis. Semin. Cancer Biol. 2004, 14:348-356.
16. McElhinny A.S., Li J.L., Wu L. Mastermind-like transcriptional co-activators: emerging roles in regulating cross talk among multiple signaling pathways. Oncogene 2008, 27:5138-5147.
17. Nam Y., Sliz P., Song L., Aster J.C., Blacklow S.C. Structural basis for cooperativity in recruitment of MAML coactivators to Notch transcription complexes. Cell 2006, 124:973-983.
18. Nam Y., Weng A.P., Aster J.C., Blacklow S.C. Structural requirements for assembly of the CSL.intracellular Notch1.Mastermind-like 1 transcriptional activation complex. J. Biol. Chem. 2003, 278:21232-21239.
19. Maillard I., Weng A.P., Carpenter A.C., Rodriguez C.G., Sai H., Xu L., Allman D., Aster J.C., Pear W.S. Mastermind critically regulates Notch-mediated lymphoid cell fate decisions. Blood 2004, 104:1696-1702.
20. Maillard I., Tu L., Sambandam A., Yashiro-Ohtani Y., Millholland J., Keeshan K., Shestova O., Xu L., Bhandoola A., Pear W.S. The requirement for Notch signaling at the beta-selection checkpoint in vivo is absolute and independent of the pre-T cell receptor. J. Exp. Med. 2006, 203:2239-2245.
21. Zhao Y., Katzman R.B., Delmolino L.M., Bhat I., Zhang Y., Gurumurthy C.B., Germaniuk-Kurowska A., Reddi H.V., Solomon A., Zeng M.S., Kung A., Ma H., Gao Q., Dimri G., Stanculescu A., Miele L., Wu L., Griffin J.D., Wazer D.E., Band H., Band V. The notch regulator MAML1 interacts with p53 and functions as a coactivator. J. Biol. Chem. 2007, 282:11969-11981.
22. Roser K., Jakel K.T., Bullerdiek J., Loning T. Significance of molecular-cytogenetic findings in mucoepidermoid carcinoma as an example of salivary gland tumors. Pathologe 2005, 26:359-366.
23. Suwanjunee S., Wongchana W., Palaga T. Inhibition of gamma-secretase affects proliferation of leukemia and hepatoma cell lines through Notch signaling. Anticancer Drugs 2008, 19:477-486.
24. Osipo C., Golde T.E., Osborne B.A., Miele L.A. Off the beaten pathway: the complex cross talk between Notch and NF-kappaB. Lab. Invest. 2008, 88:11-17.
25. Chakrabarti O., Veeraraghavalu K., Tergaonkar V., Liu Y., Androphy E.J., Stanley M.A., Krishna S. Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by notch signaling and oncogenic Ras. J. Virol. 2004, 78:5934-5945.
26. Veeraraghavalu K., Subbaiah V.K., Srivastava S., Chakrabarti O., Syal R., Krishna S. Complementation of human papillomavirus type 16 E6 and E7 by Jagged1-specific Notch1-phosphatidylinositol 3-kinase signaling involves pleiotropic oncogenic functions independent of CBF1;Su(H);Lag-1 activation. J. Virol. 2005, 79:7889-7898.